Cooley advised the underwriters on Gritstone Oncology, Inc.'s $100 million initial public offering of 6,666,667 shares of common stock. The underwriters have a 30-day option to purchase an additional 1,000,000 shares. Partners Dave Peinsipp, Drew Williamson and Charlie Kim led the Cooley team advising the underwriters.
Goldman Sachs & Co. LLC, Cowen and Barclays acted as joint book-running managers for the offering. BTIG acted as a lead manager.
Gristone Oncology is an immuno-oncology company developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company’s shares now trade on the Nasdaq Global Select Market under the symbol “GRTS.”